Improving glucocorticoid replacement profiles in adrenal insufficiency.

Area of Science:

• Endocrinology
• Pharmacology
• Internal Medicine

Background:

• Adrenal insufficiency (AI) is linked to increased mortality, exceeding two times the expected rate, even with standard glucocorticoid replacement.
• The precise causes of this elevated mortality remain unclear, potentially involving excess steroid exposure or suboptimal replacement regimens that disrupt the natural cortisol ultradian rhythm.

Purpose of the Study:

• To highlight the limitations of current oral glucocorticoid replacement therapies in mimicking physiological cortisol secretion.
• To emphasize the need for comparative studies evaluating different replacement strategies, including novel ultradian pump systems.

Main Methods:

• Review of existing literature on adrenal insufficiency pathophysiology and glucocorticoid replacement therapies.
• Discussion of emerging technologies, such as continuous subcutaneous infusion pumps, for mimicking physiological cortisol ultradian rhythms.

Main Results:

• Current oral glucocorticoid replacement cannot replicate the ultradian secretory pattern of cortisol.
• While cognitive and emotional benefits of ultradian rhythm mimicry are recognized, long-term clinical outcomes remain largely unstudied.
• A significant lack of high-quality comparative studies exists between hydrocortisone, prednisolone, and ultradian pump replacement methods.

Conclusions:

• Optimal glucocorticoid replacement strategies for adrenal insufficiency are not yet established.
• Further research, particularly direct comparative studies, is crucial to determine the most effective long-term treatment approach and improve patient survival.